Development and Progression of Alcohol-Associated Liver Disease: Effect of Aging
酒精相关肝病的发生和进展:衰老的影响
基本信息
- 批准号:10526259
- 负责人:
- 金额:$ 24.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-28 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adipose tissueAdvanced DevelopmentAgeAgingAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAnimalsBacterial TranslocationBiologicalBody CompositionCell physiologyChronicCirculationCirrhosisClinicalDefectDevelopmentDietDisease OutcomeDisease ProgressionDoseEatingElderlyEndothelial CellsEndotoxinsEnergy MetabolismEthanolExhibitsExperimental DesignsExposure toExtrahepaticFunctional disorderGastrointestinal tract structureGenderGeneticHeavy DrinkingHepaticHepatic Stellate CellHepatocyteHormonesImpairmentInflammation MediatorsInsulinInvestigationKupffer CellsLife StyleLipolysisLiverLiver CirculationLiver diseasesMetabolismMethodsMorbidity - disease rateMotor ActivityMucous MembraneNebraskaNonesterified Fatty AcidsOrganPathogenesisPathogenicityPathologyPatientsPatternPersonsPhysiologicalPlayPrimary carcinoma of the liver cellsRecording of previous eventsResearchRisk FactorsRodentRoleSamplingSeveritiesSeverity of illnessSteatohepatitisStructureTestingVirus DiseasesWater consumptionadipokinesadiponectinage effectaging populationalcohol exposurealcohol misusealcohol responsebiobankbody systemcell typechronic alcohol ingestionchronic liver diseasediet and exercisedisease phenotypedrinkingglucose uptakegut microbiotainsightintestinal barrierjuvenile animalliver injurymortalityolder patientsimple steatosistrend
项目摘要
Alcohol-associated liver disease (ALD) is a major cause of morbidity and mortality worldwide. It has an array of
liver pathologies that ranges from simple fatty liver to more severe forms of liver injury such as steatohepatitis,
cirrhosis, and hepatocellular carcinoma. Many extrahepatic factors including genetics, gender, lifestyle (diet
and exercise) and exposures to viral infections determine the disease phenotype and outcome. Equally
important in ALD pathogenesis and progression is the associated dysfunction of other organs. It is now well-
documented that the alcohol-induced changes in the gut microbiota and disruption of the intestinal barrier
integrity resulting in the increased translocation of bacterial-derived byproducts into the portal-hepatic
circulation plays a crucial pathogenic role in ALD progression. In adipose tissue, chronic ethanol consumption
enhances lipolysis, impairs insulin-activated glucose uptake, reduces secretion of protective adipokines, and
enhances release of pro-inflammatory mediators, all of which contribute to ALD pathogenesis.
Aging is a predominant risk factor for the development of advanced chronic liver diseases. Emerging evidence
indicates that advanced age is associated with alterations to the hepatic structure and impairment of cellular
functions. There are also aging-related detrimental changes in adipose tissue as well as in the composition/
stability of gut microbiota and barrier integrity. Many of these aging-related alterations in the elderly resemble
ethanol-induced defects in the liver, adipose and gut organ systems.
Based on these considerations we hypothesize that aging-related structural and functional changes in the
gastrointestinal tract, adipose and liver in older subjects promote a faster progression of ALD than in
younger subjects. Here, we propose to conduct an in-depth study to examine the effect of aging on ALD
severity. This study is warranted given the upward trend for heavy drinking among the elderly and the global
expansion in the aging population which is predicted to double to over 1.5 billion persons by 2050.
To test our hypothesis, we propose the following Specific Aims:
Specific Aim 1: Examine the aging-related structural and functional changes in the gastrointestinal tract,
adipose and liver of ethanol-fed rodents
Specific Aim 2: Gain mechanistic insight into how ethanol administration to older and younger animals for
the same duration generates more severe liver injury in older subjects
Specific Aim 3: Identify and analyze aging-related changes in patients with alcohol-associated liver disease
in relation to the severity of liver disease
酒精相关性肝病(ALD)是世界范围内发病率和死亡率的主要原因。它有一组
从单纯性脂肪肝到脂肪性肝炎等更严重的肝损伤的肝脏病理,
肝硬变和肝细胞癌。许多肝外因素,包括遗传、性别、生活方式(饮食
和运动)和接触病毒感染决定了疾病的表型和结果。同样
其他器官的相关功能障碍在ALD的发生和发展中起重要作用。现在是很好的-
研究证明,酒精导致肠道微生物区系的变化和肠道屏障的破坏
完整性导致细菌衍生的副产物更多地转移到门静脉-肝脏
循环在ALD的进展中起着重要的致病作用。在脂肪组织中,慢性酒精消费
增强脂肪分解,损害胰岛素激活的葡萄糖摄取,减少保护性脂肪因子的分泌,以及
促进促炎介质的释放,所有这些都参与了ALD的发病。
衰老是发展为晚期慢性肝病的主要危险因素。新出现的证据
提示高龄与肝脏结构改变和细胞损伤有关。
功能。也有与衰老有关的脂肪组织和成分的有害变化。
肠道微生物区系的稳定性和屏障的完整性。老年人中的许多与衰老相关的变化类似于
酒精引起的肝脏、脂肪和肠道器官系统的缺陷。
基于这些考虑,我们假设与衰老相关的结构和功能变化
老年人的胃肠道、脂肪和肝脏促进ALD的进展快于老年人
年轻的受试者。在这里,我们建议进行一项深入的研究,以检验衰老对ALD的影响
严肃性。鉴于老年人和全球酗酒者酗酒的上升趋势,这项研究是有必要的
老龄化人口的扩张,预计到2050年将翻一番,超过15亿人。
为了验证我们的假设,我们提出了以下具体目标:
具体目标1:检查与衰老有关的胃肠道的结构和功能变化,
酒精喂养啮齿类动物的脂肪和肝脏
具体目标2:获得对年长的和年轻的动物如何使用乙醇的机械性见解
同样的持续时间在老年人中会产生更严重的肝脏损伤
具体目标3:识别和分析酒精相关性肝病患者的增龄相关变化
与肝病的严重程度有关
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kusum K. Kharbanda其他文献
615 Epigenetic Regulation of iNOS, PPAR-Alpha, and Dnmt1 in the Cystathionine Beta Synthase Deficient Mouse Model of Alcoholic Steatohepatitis
- DOI:
10.1016/s0016-5085(13)63543-x - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Valentina Medici;Diane I. Schroeder;Rima Woods;Janine M. LaSalle;Sanjana Dayal;Hidekazu Tsukamoto;Kusum K. Kharbanda;Samuel W. French;Charles H. Halsted - 通讯作者:
Charles H. Halsted
Kusum K. Kharbanda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kusum K. Kharbanda', 18)}}的其他基金
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10265320 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10427223 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10620687 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
磷脂甲基化受损导致脂滴脂肪分解减少:在肝脂肪变性中的作用
- 批准号:
9900698 - 财政年份:2018
- 资助金额:
$ 24.18万 - 项目类别:
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
磷脂甲基化受损导致脂滴脂肪分解减少:在肝脂肪变性中的作用
- 批准号:
10397177 - 财政年份:2018
- 资助金额:
$ 24.18万 - 项目类别:
Alcohol and smoking concurrently aggravate chronic pancreatitis
饮酒和吸烟同时加重慢性胰腺炎
- 批准号:
9569575 - 财政年份:2017
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8438194 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8327499 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8696831 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8803254 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:














{{item.name}}会员




